Related Experiment Video
Updated: Apr 19, 2026
12:41
Acquisition of Resting-State Functional Magnetic Resonance Imaging Data in the Rat
Published on: August 28, 2021
5.0K
Low-dose intramuscular dexmedetomidine as premedication: a randomized controlled trial
Yang Sun1, Chaolei Liu2, Yuehong Zhang3
1Department of Anaesthesiology, Guangzhou First People's Hospital, Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China (mainland).
Summary
Low-dose intramuscular dexmedetomidine provides sedation and reduces anesthetic needs without causing significant bradycardia or hypotension. This study supports its use as a safe premedication option.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Dexmedetomidine can cause serious cardiovascular events like sinus arrest.
- Alternative administration routes or lower doses may mitigate these risks.
- Limited research exists on low-dose intramuscular dexmedetomidine for premedication.
Purpose of the Study:
- To evaluate the safety and efficacy of low-dose intramuscular dexmedetomidine as a premedication.
- To compare its effects on sedation, hemodynamics, and anesthetic requirements against midazolam.
Main Methods:
- 40 ASA physical status I adult patients undergoing laryngoscopic surgery were randomized.
- Groups received either intramuscular dexmedetomidine (1 µg·kg-1) or midazolam (0.02 mg·kg-1) 30 minutes pre-anesthesia.
- Sedation, anxiety, hemodynamic responses, and anesthetic agent requirements were assessed.
Main Results:
- No significant differences in sedation, anxiety, eye-opening, or extubation times between groups.
- Dexmedetomidine attenuated heart rate and mean arterial pressure responses to intubation/extubation.
- No bradycardia or hypotension occurred; propofol requirements were reduced with dexmedetomidine.
Conclusions:
- Low-dose intramuscular dexmedetomidine (1 μg·kg-1) effectively provides preoperative sedation.
- It offers adjuvant anesthetic effects with minimal cardiovascular risks.
- This route and dose appear safe for premedication, avoiding significant bradycardia or hypotension.
Related Concept Videos
01:24Parenteral Anesthetics: Overview
975
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
975
01:19Depolarizing Blockers: Pharmocokinetics
749
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
749
01:09Peripherally and Centrally Acting Muscle Relaxants: A Comparison
5.1K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
5.1K
01:11Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
967
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
967
01:31Skeletal Muscle Relaxants: Therapeutic Uses
1.2K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.2K
01:21Skeletal Muscle Relaxants: Adverse Effects
1.1K
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
1.1K